Inactive Instrument
IRLAB Therapeutics AB Stock Nasdaq Stockholm
Stocks
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| Sep. 03 | Irlab CEO Kristina Torfgaard to step down in 2027 | FW |
| Sep. 03 | Irlab CEO Kristina Torfgaard wants to step down | FW |
| Market Cap | 274M 27.41M 24.15M 22.84M 20.72M 38.9M 2.63B 39.2M 105M 1.34B 103M 101M 4.34B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 274M 27.41M 24.15M 22.84M 20.72M 38.9M 2.63B 39.2M 105M 1.34B 103M 101M 4.34B | EV / Sales 2026 * |
2.7x | EV / Sales 2027 * | 1.91x |
| Free-Float |
83.4% | Yield 2026 * |
-
| Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2024-07-31 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 2012-12-31 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 2015-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 2015-12-31 |
| Chairman | 73 | 2020-05-06 | |
Veronica Wallin
BRD | Director/Board Member | 40 | 2022-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.01% | +1.69% | +63.50% | +117.58% | 1,056B | |
| -1.61% | -0.71% | +48.89% | +70.56% | 655B | |
| -1.12% | -0.45% | +19.35% | +72.93% | 471B | |
| -1.72% | -4.25% | +37.79% | +39.89% | 342B | |
| -0.40% | +4.12% | +22.89% | +29.04% | 277B | |
| -0.51% | -1.05% | +12.98% | +12.92% | 257B | |
| +1.32% | +7.75% | +55.19% | +56.43% | 226B | |
| -0.61% | +0.48% | +34.95% | +100.58% | 189B | |
| -0.24% | -3.21% | -27.79% | -61.37% | 170B | |
| Average | -0.54% | +0.52% | +29.75% | +48.73% | 404.77B | |
| Weighted average by Cap. | -0.63% | +0.76% | +39.85% | +68.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 101M 10.14M 8.93M 8.45M 7.66M 14.39M 973M 14.5M 39M 497M 38.08M 37.25M 1.61B | 143M 14.35M 12.64M 11.95M 10.84M 20.36M 1.38B 20.51M 55.18M 703M 53.89M 52.71M 2.27B |
| Net income | -36.1M -3.62M -3.19M -3.01M -2.73M -5.13M -347M -5.17M -13.91M -177M -13.58M -13.29M -573M | 34.6M 3.47M 3.05M 2.89M 2.62M 4.92M 333M 4.96M 13.33M 170M 13.02M 12.74M 549M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Calendar
Nov. 10
Earnings release - Q3 2026
Select your edition
All financial news and data tailored to specific country editions
